Statins, Risk of Dementia and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study (GEMS)

GOAL: To examine whether lipid lowering medications (LLMs) and especially statin drugs can delay cognitive decline and dementia onset in individuals with and without Mild Cognitive Impairment (MCI) at baseline. METHODS: Longitudinal, observational study of 3,069 cognitively healthy elderly, ages 75...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bettermann, Kerstin, Arnold, Alice M., Williamson, Jeff., Rapp, Stephen, Sink, Kaycee, Toole, James F., Carlson, Michelle C., Yasar, Sevil, DeKosky, Steven, Burke, Gregory L.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140577/
https://ncbi.nlm.nih.gov/pubmed/21236699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.11.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares